BCL2 and neoplasm: As well as a range of bioactivities, they were capable of interfering with the regulation of Bcl-2 family proteins and to reactivate the intrinsic mitochondria-mediated apoptosis, reducing tumour growth in cancer xenograft models with a systemic toxicity much lower than cisplatin [46].